GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/Endoscopic Full-Thickness Resection for Extraluminal Gastric Submucosal Tumors - J of JGH - Jan,26
87

Endoscopic Full-Thickness Resection for Extraluminal Gastric Submucosal Tumors - J of JGH - Jan,26

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated January 1, 2026

Based on the context provided, the study on "Endoscopic Full-Thickness Resection (EFTR) for Extraluminal Gastric Submucosal Tumors" likely highlights the feasibility, safety, and clinical outcomes of EFTR as a minimally invasive approach for managing gastric submucosal tumors with extraluminal growth. These tumors, which grow outward from the gastric wall, pose unique challenges compared to intraluminal lesions and have been inadequately studied in the past.

Key Findings of the Study:

  1. Feasibility and Effectiveness:
  • EFTR was shown to be a feasible technique for removing gastric submucosal tumors with extraluminal growth, including those with completely extraluminal patterns.
  • The procedure achieved a high rate of complete tumor removal with successful retrieval in most cases.
  1. Safety Profile:
  • Adverse events related to the procedure were infrequent and manageable, indicating an acceptable safety profile.
  • The study supports the use of EFTR as a minimally invasive alternative to more invasive surgical techniques.
  1. Challenges and Complexity:
  • Tumor-related factors such as larger size and irregular morphology were associated with increased technical challenges, including difficulties in tumor extraction and longer operative times.
  • These factors should be carefully considered during patient selection and pre-procedural planning.
  1. Oncologic Outcomes:
  • Long-term follow-up data revealed no evidence of local recurrence or distant metastasis, suggesting that EFTR provides oncologically adequate treatment for these tumors.
  1. Clinical Implications:
  • EFTR offers a promising treatment option for patients with gastric submucosal tumors that exhibit extraluminal growth, reducing the need for more invasive surgical procedures.
  • Further studies, especially prospective trials, are needed to validate these findings and optimize patient selection criteria.

Conclusion:

The study concludes that EFTR is a safe and effective minimally invasive method for treating gastric submucosal tumors with extraluminal growth. However, tumor characteristics such as size and morphology significantly influence procedural complexity. Prospective research is recommended to refine the technique and enhance outcomes.

If you are referring to a specific article in the Journal of Gastroenterology and Hepatology (JGH) published on January 26, this summary aligns with the general findings on the topic. However, for precise details, the original article should be consulted directly.

Related Q&A

88

Reflux-Related Esophageal Stricture After POEM - J of JGH - Jan,26

Based on the context provided, the study titled "Reflux-Related Esophageal Stricture After POEM" published in the Journal of Gastroenterology and Hepatology (JGH) on January 26 likely focuses on...

89

ESD Vs TEM for Rectal Polyp

Endoscopic Submucosal Dissection (ESD) and Transanal Endoscopic Microsurgery (TEM) are both minimally invasive techniques used for the treatment of rectal polyps, particularly early-stage rectal cancer or large benign...

90

Rapid trypsinogen-2 test and post ERCP discharge Strategy - EJGH Nov 26

The study "Rapid trypsinogen-2 test and post-ERCP discharge strategy" published in the European Journal of Gastroenterology & Hepatology (EJGH) on November 26 explores methods to predict adverse events...

91

EUS, TIPS and Cavernous Transformation of the Portal Vein

EUS (Endoscopic Ultrasound), TIPS (Transjugular Intrahepatic Portosystemic Shunt), and Cavernous Transformation of the Portal Vein (CTPV) are interconnected concepts in the management of portal hypertension and its complications,...

92

REACT for colorectal ESD

REACT, which stands for Repositionable Elastic Adaptive Customizable Traction, is an innovative traction method designed to assist in Endoscopic Submucosal Dissection (ESD) for colorectal lesions. ESD is a...

93

ESD for upper esophageal cancer

Endoscopic submucosal dissection (ESD) is increasingly recognized as an effective and minimally invasive treatment option for superficial esophageal squamous neoplasms (ESN), including early-stage esophageal cancer. This technique is...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer